Login / Signup

Twelve-Month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain.

Michael FishmanHarold CordnerRafael JustizDavid Anthony ProvenzanoChristopher MerrellBinit ShahJulian NaranjoPhilip KimAaron CalodneyJonathan CarlsonRichard BundschuMahendra SanapatiVipul MangalRicardo Vallejo
Published in: Pain practice : the official journal of World Institute of Pain (2021)
Superiority of DTM SCS compared with traditional SCS for chronic LBP was demonstrated. Clinical improvements provided by DTM SCS were sustained over 12 months and are expected to significantly impact the management of chronic LBP.
Keyphrases
  • spinal cord
  • open label
  • neuropathic pain
  • spinal cord injury
  • clinical trial
  • randomized controlled trial
  • cross sectional
  • single cell
  • squamous cell carcinoma
  • phase iii
  • phase ii study
  • rectal cancer